Access to medicine across Europe: the Cystic Fibrosis case

Two years after the publication of the Pharmaceutical Strategy, patients across Europe still have different experiences when it comes to access to medicines. Following the European Cystic Fibrosis Awareness Day (21 November 2022), the MEP Lung Health Group and Cystic Fibrosis Europe have joined efforts, to talk about the current situation across the continent and how patients can have access to medicines in different countries. This event, which took place online on the 7th December 2022, brought together health professionals, experts and patients discussing the current measures and how we can continue improving access to medicines for people in Europe to live a longer and better life.